SOSV

India Social Commerce Market Intelligence Report 2024: Global Platforms are Shutting Operations in India Amid Growing Competition in the Sector - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 13, 2024

This report provides a detailed data centric analysis of the social commerce industry, covering market opportunities and risks.

Key Points: 
  • This report provides a detailed data centric analysis of the social commerce industry, covering market opportunities and risks.
  • With over 50+ KPIs at country level, this report provides a comprehensive understanding of social commerce market dynamics, market size and forecast, and market share statistics.
  • To tap into the growing sector, social commerce platforms are expected to increase their marketing spending over the medium term.
  • In-depth Understanding of Social Commerce Market Dynamics: Understand market opportunities and key trends along with forecast (2020-2029).

Feel Therapeutics Brings Michel Vounatsos as Chairman Of The Advisory Board, and Secures New Funding to Advance Digital Precision Medicine for Mental Health

Retrieved on: 
Tuesday, January 9, 2024

SAN FRANCISCO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Feel Therapeutics, the Digital Precision Medicine company for mental and behavioral health, announced today that Michel Vounatsos, former CEO of Biogen, has joined as a Chairman of their Advisory Board. Additionally, Feel has secured new funding from Satori Neuro, Metavallon VC, and existing investors such as SOSV, SeedtoB, and others, to fuel its expansion plans. Along with the new funding, Amy Kruse, Chief Investment Officer of Satori Neuro, a pioneering fund focused on mental health, neurotechnology, and human flourishing, has joined the Board of Directors as an observer. These new investors join Feel's existing group of investors, which includes Felicis, SOSV, Anthemis, SeedtoB, and others, that continue to support the company.

Key Points: 
  • SAN FRANCISCO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Feel Therapeutics , the Digital Precision Medicine company for mental and behavioral health, announced today that Michel Vounatsos, former CEO of Biogen, has joined as a Chairman of their Advisory Board.
  • Feel Therapeutics welcomes Michel Vounatsos, former Biogen CEO, as Advisory Board Chairman.
  • "I am excited to join Feel Therapeutics at this pivotal moment in their journey," said Michel Vounatsos.
  • Feel's approach to precision medicine in mental & behavioral health can transform how we manage, monitor, and treat those conditions.

Lingrove Secures $10 Million in Financing to Ramp up Production of ekoa® - Plant-based Surfaces and Panels for Climate-friendly, Healthy Interiors

Retrieved on: 
Monday, December 18, 2023

The funding enables Lingrove to ramp up production of ekoa®, a natural, durable, and carbon-negative alternative to conventional materials used in construction.

Key Points: 
  • The funding enables Lingrove to ramp up production of ekoa®, a natural, durable, and carbon-negative alternative to conventional materials used in construction.
  • Lingrove aims to reinvent and decarbonize the trillion-dollar renovation and new construction materials market, making interiors healthy, beautiful, and climate-friendly.
  • Lingrove, which launched inhouse manufacturing of ekoa® surfaces in late 2023, has secured millions in ekoa® pre-orders.
  • Despite a challenging fundraising environment, Lingrove successfully secured strategic financing to foster a better future through fast-growing plants, starting with healthy and beautiful interiors.

Monozukuri Ventures Launches "Deep Tech Forum" and Brings It to Three North American Cities in January 2024 and Japan in March 2024

Retrieved on: 
Monday, November 20, 2023

KYOTO, Japan and NEW YORK, Nov. 20, 2023 /PRNewswire-PRWeb/ -- Monozukuri Ventures, a venture capital firm focused on hardware and deep tech startups, today announced the launch of the Deep Tech Forum, where the world's leading deep tech startup ecosystem of founders, startups, investors and supporting communities will come together to address the barriers to growth and success.

Key Points: 
  • "Accelerators and VC support alone are not enough for deep tech startups.
  • The Deep Tech Forum in Kyoto is scheduled to be held on March 7th and 8th, 2024.
  • "Accelerators and VC support alone are not enough for deep tech startups, especially those spun out of universities.
  • The BDC Deep Tech Venture Fund is Canada's largest VC fund ($200 million) dedicated to deep tech.

Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing

Retrieved on: 
Thursday, November 9, 2023

Cromatic , a full-stack digital platform for outsourced life sciences research, today announced it has closed $5.3 million in funding.

Key Points: 
  • Cromatic , a full-stack digital platform for outsourced life sciences research, today announced it has closed $5.3 million in funding.
  • LifeX Ventures and AgFunder led the round with participation from Work Life Ventures, Not Boring Capital, FJ Labs, What If Ventures, Lux Capital, and angel investors.
  • The demand for biotech and pharmaceutical R&D outsourcing is growing rapidly and is expected to be worth $275 billion by 2030.
  • Cromatic is harnessing this newfound capacity in a coherent platform for a new generation of nimble and capital-efficient biotech companies.

Backbar rebrands to Sidework as it raises new capital, bringing total raised over $10 million

Retrieved on: 
Wednesday, October 25, 2023

SAN DIEGO, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Sidework, a pioneering beverage technology company formerly known as Backbar, has closed new funding to bring their total raised to over $10 million. A testament to the industry's confidence in its game-changing technology, the new money is led by Cherubic Ventures with continuing participation from Finistere Ventures, SOSV, Outlander Labs, and Pathbreaker Ventures. Matt Cheng, Cherubic Ventures' general partner, said the following: "We believe in Sidework's vision to revolutionize the beverage industry. This funding marks an exciting milestone, reflecting the pivotal role they are playing to reshape how beverages are crafted and served." The rebrand signifies Sidework's broadened scope, where customers can dispense drinks, manage inventory, and buy ingredients through Sidework's hardware, software, and marketplace ecosystem.

Key Points: 
  • Matt Cheng, Cherubic Ventures' general partner, said the following: "We believe in Sidework's vision to revolutionize the beverage industry.
  • This funding marks an exciting milestone, reflecting the pivotal role they are playing to reshape how beverages are crafted and served."
  • The rebrand signifies Sidework's broadened scope, where customers can dispense drinks, manage inventory, and buy ingredients through Sidework's hardware, software, and marketplace ecosystem.
  • Sidework's ecosystem addresses two fundamental challenges: Not enough venues serve great tasting, modern drinks and those drinks are extremely difficult to make.

Biomaterials Startup GOZEN Raises $3.3 Million In Seed Funding

Retrieved on: 
Wednesday, October 25, 2023

SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- GOZEN, the revolutionary biomaterials startup that is set to disrupt the fashion, automotive and home furnishings industries, has just announced $3.3 million in a seed funding round.

Key Points: 
  • SAN FRANCISCO, Oct. 25, 2023 /PRNewswire/ -- GOZEN, the revolutionary biomaterials startup that is set to disrupt the fashion, automotive and home furnishings industries, has just announced $3.3 million in a seed funding round.
  • This investment will enable GOZEN to accelerate research, development, and scaling efforts for its breakthrough biomaterial, LUNAFORM™, and fuel the creation of new materials.
  • GOZEN is on a mission to replace traditional materials in the fashion and automotive industries by producing a range of high-performing vegan and plastic-free materials.
  • With this investment, we've shown that we have a path to delivering on that potential at scale," says Ece Gozen, founder and CEO of GOZEN.

Mimio Health Commercially Launches Groundbreaking Biomimetic Based on the Science of Fasting to Promote Cellular Health and Longevity

Retrieved on: 
Thursday, October 19, 2023

SAN FRANCISCO, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Mimio Health, the biomimetic human health company, announced today the commercial launch of their flagship product, Mimio. Mimio is a biomimetic designed from human biology to unlock the cellular health and longevity benefits of long-term fasting, without needing to fast. By upregulating and enhancing these cellular processes, Mimio supercharges the body's natural restorative abilities.

Key Points: 
  • Mimio is a biomimetic designed from human biology to unlock the cellular health and longevity benefits of long-term fasting, without needing to fast.
  • Mimio is a biomimetic designed from human biology to unlock the cellular health and longevity benefits of long-term fasting, without needing to fast.
  • Fasting has been shown across thousands of studies to be one of the most powerful ways to enhance health and promote longevity.
  • Using fasting as a roadmap, Mimio Health's biomimetic research has studied and decoded the changes that happen in the body to activate this innate longevity bio-program.

Leading Remote Health Care Company Optimize Health Completes $18 Million Series B Financing

Retrieved on: 
Tuesday, October 10, 2023

SEATTLE, Oct. 10, 2023 /PRNewswire/ -- Optimize Health, one of the most trusted remote healthcare platforms in the U.S., today announced the completion of its latest financing, raising more than $18 million.

Key Points: 
  • SEATTLE, Oct. 10, 2023 /PRNewswire/ -- Optimize Health, one of the most trusted remote healthcare platforms in the U.S., today announced the completion of its latest financing, raising more than $18 million.
  • The Series B round was led by Foundry and Escalate Capital Partners, with participation from Bonfire Ventures, Daher Capital, Navigate Ventures, Attento Capital, OpenView, 500 Global, SOSV, and Jumpstart Capital.
  • Seattle-based Optimize Health is revolutionizing the healthcare industry through its innovative technology and services to support remote care.
  • The company leverages a leading remote patient monitoring and chronic care management software platform to improve patient outcomes, enhance clinical decision-making, and optimize operational efficiency for healthcare providers.

FluidAI Medical Announces $15M in Series A Funding for AI-Driven Postoperative Monitor at HLTH 2023

Retrieved on: 
Tuesday, October 10, 2023

MedTech FluidAI Medical secures funding to empower healthcare providers with data-driven insights to transform postoperative care.

Key Points: 
  • MedTech FluidAI Medical secures funding to empower healthcare providers with data-driven insights to transform postoperative care.
  • Following any surgical intervention, there are inherent risks of adverse outcomes, irrespective of how minor or major the procedure may be.
  • At FluidAI, our goal is to continuously push the boundaries of what's possible in postoperative care, ensuring patients recover safely and quickly.
  • "With FluidAI, surgeons can ensure better clinical outcomes, shorter hospital stays for patients, and cost efficiencies across the healthcare ecosystem.